Xu, Heng; Cheng, Cheng; Devidas, Meenakshi et al. (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 30:751-7
|
Yang, Jun J; Cheng, Cheng; Devidas, Meenakshi et al. (2011) Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 43:237-41
|
Phillips, Christine L; Gerbing, Robert; Alonzo, Todd et al. (2010) MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer 55:248-53
|
Yang, Jun J; Cheng, Cheng; Yang, Wenjian et al. (2009) Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 301:393-403
|
Bhatla, Deepika; Gerbing, Robert B; Alonzo, Todd A et al. (2009) Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. Br J Haematol 144:388-94
|
Yang, Jun J; Bhojwani, Deepa; Yang, Wenjian et al. (2008) Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood 112:4178-83
|
Bhatla, D; Gerbing, R B; Alonzo, T A et al. (2008) DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group. Leukemia 22:265-72
|
Mehta, Parinda A; Gerbing, Robert B; Alonzo, Todd A et al. (2008) FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report. Clin Cancer Res 14:7896-9
|
Davies, Stella M; Borowitz, Michael J; Rosner, Gary L et al. (2008) Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 111:2984-90
|